You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. BIOACTIVE POLYMER FOR VENTRICULAR ASSIST DEVICES- SBIR TOPIC #37

    SBC: ABIOMED, INC.            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  2. SBIR PHASE I: ANTIBODY ARRAY FOR CANCER DETECTION

    SBC: ADVANSTA, INC.            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  3. Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer

    SBC: ADVANTAGENE, INC            Topic: N/A

    DESCRIPTION (provided by applicant): The main objective of this project is to develop a new therapeutic to improve the outcome for patients with intermediate-risk prostate cancer. The indication is a first-line adjuvant to be combined with radiation therap y for prostate cancer. The desired outcomes are improved local control rate, decreased recurrence and improved disease-free survival. This gran ...

    SBIR Phase I 2007 Department of Health and Human Services
  4. Study of CdZnTe Electrode Interface and Fabrication Technology Development

    SBC: Aguila Technologies, Inc.            Topic: N/A

    Not avaiable.

    STTR Phase II 2007 Department of Health and Human Services
  5. SBIR PHASE I, TOPIC 239 YEAST SINGLE CHAIN ANTIBODIES AS CAPTURE REAGENTS

    SBC: ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  6. Computer-aided tool for diagnostic breast ultrasound

    SBC: ALMEN LABORATORIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In current medical practice, breast biopsy serves as the gold standard for determining if a breast mass is benign or malignant. Mammography is the main imaging procedure (screening) for detecting suspicious findings with its high sensitivity but its lower specificity (false positives) is well documented. With increased emphasis on early detection of breast canc ...

    SBIR Phase II 2007 Department of Health and Human Services
  7. Alkylating Vitamin D Derivative

    SBC: APHIOS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Prostate cancer is the most prevalent cancer among men; and the second leading cause of cancer death among men in the US. There are currently no approved therapies for hormone-refractory prostate cancer. Epidemiological studies have demonstrated a strong relationship between incidence of and mortality from various cancers including prostate cancer, exposure to ...

    STTR Phase I 2007 Department of Health and Human Services
  8. Not avaiable

    SBC: ATLANTIC PHARMACEUTICALS, INC.            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  9. SBIR TOPIC 241- TARGETED NANOPARTICLES FOR PROSTATE CANCER THERAPY

    SBC: BIND BIOSCIENCES, INC.            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  10. SBIR TOPIC 229 A ROBUST AND RIGOROUS PHARMACODYNAMIC ASSAY FOR AKT

    SBC: BIOASSAY SYSTEMS, LLC            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
US Flag An Official Website of the United States Government